IP Library Patent Application 16330304
Patent Application
App. No. 16/330,304

PROCESSES FOR SEPARATING AGGREGATED PROTEINS FROM MONOMERIC PROTEINS IN A BIOLOGICAL SOLUTION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/330,304
Abstract

A process for separating aggregated proteins from monomeric proteins in a biological solution, the process including: providing at least one filter element having a contacting surface, wherein the filter element comprises filter media comprising: a porous substrate; and disposed on the porous substrate, a polymer comprising a hydrocarbon backbone and a plurality of pendant groups attached to the hydrocarbon backbone, wherein each of a first plurality of pendant groups comprises: (1) at least one acidic group or salt thereof; and (2) a spacer group that directly links the at least one acidic group or salt thereof to the hydrocarbon backbone by a chain of at least 6 catenated atoms; and allowing an initial biological solution to contact the contacting surface of the filter element N under conditions effective to separate the aggregated proteins from the monomeric proteins such that a final biological solution includes purified monomeric proteins.

Claims (24)

1 . A process for separating aggregated proteins from monomeric proteins in a biological solution, the process comprising:

providing at least one filter element having a contacting surface, wherein the filter element comprises filter media comprising:

a porous substrate; and

disposed on the porous substrate, a polymer comprising a hydrocarbon backbone and a plurality of pendant groups attached to the hydrocarbon backbone, wherein each of a first plurality of pendant groups comprises:

(1) at least one acidic group or salt thereof; and

(2) a spacer group that directly links the at least one acidic group or salt thereof to the hydrocarbon backbone by a chain of at least 6 catenated atoms; and

allowing an initial biological solution to contact the contacting surface of the filter element under conditions effective to separate the aggregated proteins from the monomeric proteins such that a final biological solution includes purified monomeric proteins.

2 . The process of claim 1 wherein the polymer comprises interpolymerized units of at least one monomer comprising:

(1) at least one ethylenically unsaturated group;

(2) at least one acidic group or salt thereof; and

(3) a spacer group that directly links the at least one ethylenically unsaturated group and the at least one acidic group or salt thereof by a chain of at least 6 catenated atoms.

3 . The process of claim 1 further comprising recovering the monomeric proteins without eluting.

4 . The process of claim 1 wherein the conditions are effective to recover, in the final solution, at least 70% of the monomeric proteins present in the initial biological solution.

5 . The process of claim 1 wherein the conditions are effective to remove at least 10% of the aggregated proteins from the initial biological solution.

6 . The process of claim 1 wherein the proteins comprise antibodies, enzymes, or hormones.

7 . The process of claim 6 wherein the proteins comprise antibodies.

8 . The process of claim 1 wherein the conditions comprise a pH of the biological solution of below 9.

9 . The process of claim 1 wherein the conditions comprise a conductivity of the biological solution of at least 1 mS/cm.

10 . The process of claim 1 wherein the at least one acidic group or salt thereof of the polymer disposed on the porous substrate is present at a density of at least 0.02 mmole/gram of filter media.

11 . The process of claim 2 wherein the at least one ethylenically unsaturated group is selected from an ethenyl group, a 1-alkylethenyl group, and a combination thereof.

12 . The process of claim 1 wherein the chain of the spacer group has at least 8 catenated atoms.

13 . The process of claim 1 wherein the at least one acidic group or salt thereof is selected from a carboxy group, a phosphono group, a phosphato group, a sulfono group, a sulfato group, a boronato group, and a combination thereof.

14 . The process of claim 1 wherein the spacer group is a catenated heteroatom-containing hydrocarbon group.

15 . The process of claim 1 wherein the spacer group comprises at least one hydrogen bonding moiety.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066431/0915 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2019
From: COLAK ATAN, SEMRA; VAIL, ANDREW W.; RASMUSSEN, JERALD K.; GRIESGRABER, GEORGE W.; BOTHOF, CATHERINE A.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 048495/0209 →